相似文献
1
The Role of Human Endogenous Retroviruses in Cancer Immunotherapy of the Post-COVID-19 World.
Cancers (Basel). 2023 Nov 7;15(22):5321. doi: 10.3390/cancers15225321.
2
'A blessing in disguise': myxoma cordis and Tako Tsubo cardiomyopathy.
Eur Heart J. 2015 Apr 14;36(15):914. doi: 10.1093/eurheartj/ehu496. Epub 2015 Jan 1.
3
COVID19: A blessing in disguise for European stock markets?
Financ Res Lett. 2022 Oct;49:103135. doi: 10.1016/j.frl.2022.103135. Epub 2022 Jul 7.
4
Either 'a blessing in disguise', or 'I couldn't get help,': Australian and Aotearoa NZ women's experiences of early infant feeding during COVID-19.
Women Birth. 2023 May;36(3):e305-e313. doi: 10.1016/j.wombi.2022.11.003. Epub 2022 Nov 26.
5
COVID-19: Lessons for the climate change emergency.
Sci Total Environ. 2020 Nov 10;742:140563. doi: 10.1016/j.scitotenv.2020.140563. Epub 2020 Jun 27.
6
COVID-19 pandemic and environmental pollution: A blessing in disguise?
Sci Total Environ. 2020 Aug 1;728:138820. doi: 10.1016/j.scitotenv.2020.138820. Epub 2020 Apr 20.
7
COVID-19, a blessing in disguise for the Tech sector: Evidence from stock price crash risk.
Res Int Bus Finance. 2023 Apr;65:101938. doi: 10.1016/j.ribaf.2023.101938. Epub 2023 Mar 30.
8
Omicron: A Blessing in Disguise?
Front Public Health. 2022 May 2;10:875022. doi: 10.3389/fpubh.2022.875022. eCollection 2022.
9
Sirolimus in a Renal Transplant Recipient Infected With COVID-19: A Blessing in Disguise?
Cureus. 2021 Aug 11;13(8):e17102. doi: 10.7759/cureus.17102. eCollection 2021 Aug.
10
Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients.
Microbiol Spectr. 2021 Oct 31;9(2):e0126021. doi: 10.1128/Spectrum.01260-21. Epub 2021 Oct 6.
本文引用的文献
1
Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas.
Cancers (Basel). 2023 Jul 18;15(14):3664. doi: 10.3390/cancers15143664.
2
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.
Cancers (Basel). 2023 Jun 30;15(13):3448. doi: 10.3390/cancers15133448.
3
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Cancers (Basel). 2023 May 12;15(10):2733. doi: 10.3390/cancers15102733.
4
An Endogenous Retrovirus Vaccine Encoding an Envelope with a Mutated Immunosuppressive Domain in Combination with Anti-PD1 Treatment Eradicates Established Tumours in Mice.
Viruses. 2023 Apr 6;15(4):926. doi: 10.3390/v15040926.
5
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Nature. 2023 Apr;616(7957):563-573. doi: 10.1038/s41586-023-05771-9. Epub 2023 Apr 12.
6
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects.
Vaccines (Basel). 2023 Mar 13;11(3):636. doi: 10.3390/vaccines11030636.
7
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens.
Nat Rev Nephrol. 2023 Jul;19(7):440-450. doi: 10.1038/s41581-023-00700-5. Epub 2023 Mar 27.
8
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.
Nat Biotechnol. 2023 Nov;41(11):1618-1632. doi: 10.1038/s41587-023-01684-0. Epub 2023 Mar 13.
9
mRNA-Based Therapeutics in Cancer Treatment.
Pharmaceutics. 2023 Feb 13;15(2):622. doi: 10.3390/pharmaceutics15020622.
10
mRNA-From COVID-19 Treatment to Cancer Immunotherapy.
Biomedicines. 2023 Jan 22;11(2):308. doi: 10.3390/biomedicines11020308.
Zotero 插件